We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TD icon
101
Toronto Dominion Bank
TD
$193B
$49.2M 0.19%
844,382
+68,682
+9% +$3.9M
NOC icon
102
Northrop Grumman
NOC
$76B
$49M 0.19%
130,818
+7,072
+6% +$2.5M
PNC icon
103
PNC Financial Services
PNC
$99.1B
$48.9M 0.19%
348,826
-3,488
-1% -$473K
LIN icon
104
Linde
LIN
$236B
$48.1M 0.19%
248,547
+11,794
+5% +$2.28M
CME icon
105
CME Group
CME
$95.4B
$48M 0.19%
227,171
+16,204
+8% +$3.39M
SNY icon
106
Sanofi
SNY
$107B
$47.8M 0.19%
1,032,474
-83,667
-7% -$3.61M
HSY icon
107
Hershey
HSY
$37.3B
$47.6M 0.19%
306,987
+83,333
+37% +$12.6M
ED icon
108
Consolidated Edison
ED
$41.4B
$47.6M 0.19%
503,432
-50,169
-9% -$4.45M
BMY icon
109
Bristol-Myers Squibb
BMY
$129B
$47.5M 0.19%
937,159
+157,369
+20% +$7.4M
DEO icon
110
Diageo
DEO
$49.6B
$47.5M 0.19%
290,449
+8,943
+3% +$1.5M
CHL
111
DELISTED
China Mobile Limited
CHL
$47.4M 0.19%
1,144,435
-243,200
-18% -$10.4M
SAP icon
112
SAP
SAP
$215B
$46.9M 0.19%
397,885
-27,433
-6% -$3.4M
CHT icon
113
Chunghwa Telecom
CHT
$33.5B
$46.5M 0.18%
1,302,028
-66,359
-5% -$2.33M
GILD icon
114
Gilead Sciences
GILD
$165B
$46M 0.18%
725,363
-31,562
-4% -$2.06M
ZTS icon
115
Zoetis
ZTS
$32.7B
$45.9M 0.18%
368,581
+34,016
+10% +$4.11M
SMFG icon
116
Sumitomo Mitsui Financial
SMFG
$159B
$45.8M 0.18%
6,689,099
+924,123
+16% +$6.31M
CAT icon
117
Caterpillar
CAT
$361B
$45.2M 0.18%
357,548
-26,140
-7% -$3.32M
GSK icon
118
GSK
GSK
$107B
$44.9M 0.18%
841,677
+71,636
+9% +$3.69M
AWK icon
119
American Water Works
AWK
$27B
$44.9M 0.18%
361,279
+2,944
+0.8% +$355K
WM icon
120
Waste Management
WM
$95B
$44.8M 0.18%
389,906
+13,151
+3% +$1.54M
SPGI icon
121
S&P Global
SPGI
$124B
$44.8M 0.18%
183,023
+5,205
+3% +$1.3M
CSX icon
122
CSX Corp
CSX
$94B
$44.8M 0.18%
1,939,698
-65,676
-3% -$1.53M
GIB icon
123
CGI
GIB
$15.4B
$44.8M 0.18%
565,915
+42,037
+8% +$3.28M
APD icon
124
Air Products & Chemicals
APD
$65.5B
$44.5M 0.18%
200,568
+978
+0.5% +$220K
HSBC icon
125
HSBC
HSBC
$352B
$44.4M 0.18%
1,161,326
-524,858
-31% -$20.3M
3 4
5
6 7

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.